Cargando…

Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis

BACKGROUND: Adipose-derived mesenchymal stem cells (ASCs) have gained attention as a new treatment for systemic sclerosis (SSc). Low-molecular-weight heparin (LMWH) enhances cell function and stimulates the production of hepatocyte growth factor (HGF) in a variety of cells. This study investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuka, Takayasu, Kotani, Takuya, Saito, Takashi, Matsuda, Shogo, Sato, Takako, Takeuchi, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540693/
https://www.ncbi.nlm.nih.gov/pubmed/36207753
http://dx.doi.org/10.1186/s13075-022-02915-6
_version_ 1784803760435888128
author Suzuka, Takayasu
Kotani, Takuya
Saito, Takashi
Matsuda, Shogo
Sato, Takako
Takeuchi, Tohru
author_facet Suzuka, Takayasu
Kotani, Takuya
Saito, Takashi
Matsuda, Shogo
Sato, Takako
Takeuchi, Tohru
author_sort Suzuka, Takayasu
collection PubMed
description BACKGROUND: Adipose-derived mesenchymal stem cells (ASCs) have gained attention as a new treatment for systemic sclerosis (SSc). Low-molecular-weight heparin (LMWH) enhances cell function and stimulates the production of hepatocyte growth factor (HGF) in a variety of cells. This study investigated the effects of LMWH on the functions of mouse ASCs (mASCs), and the therapeutic effects of mASCs activated with LMWH (hep-mASCs) in mouse models of SSc. METHODS: The cellular functions of mASCs cultured with different concentrations of LMWH were determined. Mice were divided into four groups: bleomycin (BLM)-induced SSc (BLM-alone), BLM-induced SSc administered with mASCs (BLM-mASC), and BLM-induced SSc administered with mASCs activated with 10 or 100 μg/mL LMWH (BLM-hep-mASC); there were 9 mice per group (n = 9). Skin inflammation and fibrosis were evaluated using histological and biochemical examinations and gene expression levels. RESULTS: In vitro assays showed that migration ability and HGF production were significantly higher in hep-mASCs than in mASCs alone. The mRNA expression levels of cell migration factors were significantly upregulated in hep-mASCs compared to those in mASCs alone. The hep-mASCs accumulated in the skin tissues more than mASCs alone. The thickness of skin and hydroxyproline content in BLM-hep-mASC groups were significantly decreased, and the skin mRNA expression levels of interleukin-2, α-smooth muscle actin, transforming growth factor β1, collagen type 1 alpha 1, and tissue inhibitor of metalloproteinase 2 were significantly downregulated compared to those in the BLM-alone group. CONCLUSIONS: hep-mASCs showed higher anti-inflammatory and anti-fibrotic effects than mASCs alone and may be a promising candidate for SSc treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02915-6.
format Online
Article
Text
id pubmed-9540693
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95406932022-10-08 Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis Suzuka, Takayasu Kotani, Takuya Saito, Takashi Matsuda, Shogo Sato, Takako Takeuchi, Tohru Arthritis Res Ther Research BACKGROUND: Adipose-derived mesenchymal stem cells (ASCs) have gained attention as a new treatment for systemic sclerosis (SSc). Low-molecular-weight heparin (LMWH) enhances cell function and stimulates the production of hepatocyte growth factor (HGF) in a variety of cells. This study investigated the effects of LMWH on the functions of mouse ASCs (mASCs), and the therapeutic effects of mASCs activated with LMWH (hep-mASCs) in mouse models of SSc. METHODS: The cellular functions of mASCs cultured with different concentrations of LMWH were determined. Mice were divided into four groups: bleomycin (BLM)-induced SSc (BLM-alone), BLM-induced SSc administered with mASCs (BLM-mASC), and BLM-induced SSc administered with mASCs activated with 10 or 100 μg/mL LMWH (BLM-hep-mASC); there were 9 mice per group (n = 9). Skin inflammation and fibrosis were evaluated using histological and biochemical examinations and gene expression levels. RESULTS: In vitro assays showed that migration ability and HGF production were significantly higher in hep-mASCs than in mASCs alone. The mRNA expression levels of cell migration factors were significantly upregulated in hep-mASCs compared to those in mASCs alone. The hep-mASCs accumulated in the skin tissues more than mASCs alone. The thickness of skin and hydroxyproline content in BLM-hep-mASC groups were significantly decreased, and the skin mRNA expression levels of interleukin-2, α-smooth muscle actin, transforming growth factor β1, collagen type 1 alpha 1, and tissue inhibitor of metalloproteinase 2 were significantly downregulated compared to those in the BLM-alone group. CONCLUSIONS: hep-mASCs showed higher anti-inflammatory and anti-fibrotic effects than mASCs alone and may be a promising candidate for SSc treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02915-6. BioMed Central 2022-10-07 2022 /pmc/articles/PMC9540693/ /pubmed/36207753 http://dx.doi.org/10.1186/s13075-022-02915-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Suzuka, Takayasu
Kotani, Takuya
Saito, Takashi
Matsuda, Shogo
Sato, Takako
Takeuchi, Tohru
Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
title Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
title_full Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
title_fullStr Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
title_full_unstemmed Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
title_short Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
title_sort therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540693/
https://www.ncbi.nlm.nih.gov/pubmed/36207753
http://dx.doi.org/10.1186/s13075-022-02915-6
work_keys_str_mv AT suzukatakayasu therapeuticeffectsofadiposederivedmesenchymalstemstromalcellswithenhancedmigrationabilityandhepatocytegrowthfactorsecretionbylowmolecularweightheparintreatmentinbleomycininducedmousemodelsofsystemicsclerosis
AT kotanitakuya therapeuticeffectsofadiposederivedmesenchymalstemstromalcellswithenhancedmigrationabilityandhepatocytegrowthfactorsecretionbylowmolecularweightheparintreatmentinbleomycininducedmousemodelsofsystemicsclerosis
AT saitotakashi therapeuticeffectsofadiposederivedmesenchymalstemstromalcellswithenhancedmigrationabilityandhepatocytegrowthfactorsecretionbylowmolecularweightheparintreatmentinbleomycininducedmousemodelsofsystemicsclerosis
AT matsudashogo therapeuticeffectsofadiposederivedmesenchymalstemstromalcellswithenhancedmigrationabilityandhepatocytegrowthfactorsecretionbylowmolecularweightheparintreatmentinbleomycininducedmousemodelsofsystemicsclerosis
AT satotakako therapeuticeffectsofadiposederivedmesenchymalstemstromalcellswithenhancedmigrationabilityandhepatocytegrowthfactorsecretionbylowmolecularweightheparintreatmentinbleomycininducedmousemodelsofsystemicsclerosis
AT takeuchitohru therapeuticeffectsofadiposederivedmesenchymalstemstromalcellswithenhancedmigrationabilityandhepatocytegrowthfactorsecretionbylowmolecularweightheparintreatmentinbleomycininducedmousemodelsofsystemicsclerosis